Novartis AG Revenue

In the year 2024, Novartis AG had annual revenue of $51.72B with 10.85% growth. Novartis AG had revenue of $13.56B in the quarter ending December 31, 2024, with 15.13% growth.

Revenue

51.72B

Revenue Growth

+10.85%

P/S Ratio

n/a

Revenue / Employee

681.60K

Employees

75,883

Market Cap

215.54B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	51.72B	5.06B	10.85%
Dec 31, 2023	46.66B	3.20B	7.36%
Dec 31, 2022	43.46B	-513.00M	-1.17%
Dec 31, 2021	43.97B	-5.92B	-11.87%
Dec 31, 2020	49.90B	1.22B	2.51%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.79B
SS Innovations International	16.04M
Veradigm	1.53B
Elite Pharmaceuticals	70.00M
Glass House Brands	188.29M
Northwest Biotherapeutics	1.60M
BioStem Technologies	210.49M
SANUWAVE Health	29.30M

Revenue Rankings

Novartis AG News

4 days ago - Novartis Invests $7.5M to Promote Early Prostate Cancer Testing in Vulnerable Communities - CNBC
8 days ago - Novartis: Strong Execution With A P/E Discount - Seeking Alpha
8 days ago - Key deals this week: Papa John's, Spirit Airlines, Novartis, Banco Santander and more - Seeking Alpha
10 days ago - Novartis: Just What The Doctor Ordered - Seeking Alpha
13 days ago - Novartis agrees $3bn deal to buy heart drug biotech from Blackstone - Financial Times
13 days ago - Novartis to buy Anthos Therapeutics for up to $3.1B - Seeking Alpha
13 days ago - Novartis agrees to acquire Anthos for up to $3.1 bln - Reuters
13 days ago - Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 Billion - Business Wire

More News